444909-59-5 Usage
Uses
Used in Pharmaceutical Industry:
5-Thiazolecarboxylic acid, 4-chloro-, is used as a building block for the synthesis of important drugs. Its unique structure allows for the development of new pharmaceutical compounds with potential therapeutic applications.
Used in Agrochemical Industry:
In the agrochemical sector, 5-Thiazolecarboxylic acid, 4-chloro-, is utilized as a key intermediate in the production of agricultural chemicals. Its properties contribute to the creation of effective compounds for pest control and crop protection.
Used in Material Science:
5-Thiazolecarboxylic acid, 4-chloro-, has potential applications in the development of new materials. Its unique chemical structure can be leveraged to create innovative materials with specific properties for various industries.
Used in Chemical Process Development:
5-Thiazolecarboxylic acid, 4-chloroalso plays a role in the advancement of chemical processes. Its reactivity and structural features can be harnessed to improve or create new chemical synthesis methods, enhancing the efficiency and effectiveness of chemical production.
Check Digit Verification of cas no
The CAS Registry Mumber 444909-59-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 4,4,4,9,0 and 9 respectively; the second part has 2 digits, 5 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 444909-59:
(8*4)+(7*4)+(6*4)+(5*9)+(4*0)+(3*9)+(2*5)+(1*9)=175
175 % 10 = 5
So 444909-59-5 is a valid CAS Registry Number.
InChI:InChI=1/C4H2ClNO2S/c5-3-2(4(7)8)9-1-6-3/h1H,(H,7,8)
444909-59-5Relevant academic research and scientific papers
Substituted 3-aryl-5-aryl-[1,2,4]-oxadiazoles and analogs as activators of caspases and inducers of apoptosis and the use thereof
-
, (2008/06/13)
The present invention is directed to substituted 3-aryl-5-aryl-[1,2,4]-oxadiazoles and analogs thereof, represented by the Formula I: wherein Ar1, Ar3, A, B and D are defined herein. The present invention also relates to the discovery that compounds having Formula I are activators of caspases and inducers of apoptosis. Therefore, the activators of caspases and inducers of apoptosis of this invention may be used to induce cell death in a variety of clinical conditions in which uncontrolled growth and spread of abnormal cells occurs.
